Role of positron emission tomography in lung cancer

The ability to demonstrate tumour foci that are undetected by conventional imaging has resulted in the emergence of positron emission tomography (PET) as a valuable clinical tool in oncology. This article describes the technique and indications for fluorine-18 labelled fluorodeoxyglucose (18FDG)-PET...

Full description

Bibliographic Details
Main Author: Miles, K. A.
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554689/
id pubmed-4554689
recordtype oai_dc
spelling pubmed-45546892015-09-02 Role of positron emission tomography in lung cancer Miles, K. A. Review The ability to demonstrate tumour foci that are undetected by conventional imaging has resulted in the emergence of positron emission tomography (PET) as a valuable clinical tool in oncology. This article describes the technique and indications for fluorine-18 labelled fluorodeoxyglucose (18FDG)-PET in lung cancer, demonstrating the high accuracy and cost-effectiveness of 18FDG-PET in the characterisation of solitary pulmonary nodules and in the pre-operative staging of non-small cell lung cancer. Emerging roles in determination of prognosis, radiotherapy planning, therapy monitoring and diagnosis of recurrence are illustrated. BioMed Central 2015-05-05 /pmc/articles/PMC4554689/ http://dx.doi.org/10.1102/1470-7330.2002.0006 Text en © International Cancer Imaging Society 2002
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Miles, K. A.
spellingShingle Miles, K. A.
Role of positron emission tomography in lung cancer
author_facet Miles, K. A.
author_sort Miles, K. A.
title Role of positron emission tomography in lung cancer
title_short Role of positron emission tomography in lung cancer
title_full Role of positron emission tomography in lung cancer
title_fullStr Role of positron emission tomography in lung cancer
title_full_unstemmed Role of positron emission tomography in lung cancer
title_sort role of positron emission tomography in lung cancer
description The ability to demonstrate tumour foci that are undetected by conventional imaging has resulted in the emergence of positron emission tomography (PET) as a valuable clinical tool in oncology. This article describes the technique and indications for fluorine-18 labelled fluorodeoxyglucose (18FDG)-PET in lung cancer, demonstrating the high accuracy and cost-effectiveness of 18FDG-PET in the characterisation of solitary pulmonary nodules and in the pre-operative staging of non-small cell lung cancer. Emerging roles in determination of prognosis, radiotherapy planning, therapy monitoring and diagnosis of recurrence are illustrated.
publisher BioMed Central
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554689/
_version_ 1613470890451795968